Subscribe
Menu
Login
Search
Login
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
May 2022, Issue 2
Preview This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2022
Preview This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
Multimedia
Crossword Puzzles
Infographics
Science Snapshot
Videos
Webinars
Research Resources
Podcasts
Events
Infographics
eBooks
Videos
The Scientist University
Research Products Blog
Articles
Subscribe
Home
Subjects
off-label drug
off-label drug
Off-Label Drug Disclosure Inadequate
Hayley Dunning | Aug 7, 2012
Some 85 percent of researchers involved in promoting off-label drug use do not adequately disclose financial conflicts of interest in published articles.
